Metrica Partners urges SK Chemicals to sell SK Bioscience shares upon the lockup expiry
- The board of SK Chemicals seems unconcerned with its shares trading at an 83% discount to net asset value. In Metrica’s view, the board has a fiduciary duty to care about its share price.
- The company should address the discount by selling a stake in its subsidiary SK Bioscience upon the IPO lock-up expiry of 18 September and distributing the proceeds to shareholders.
- SK Chemicals can pay a special dividend of 1.3x its share price while still retaining 50% ownership in SK Bioscience as well as 100% ownership of its profitable chemical and pharmaceutical businesses.
Record Q1 for M&A
M&A activity in Asia-Pacific is trending at a post-GFC record:
Several drivers exist in our view: ... more
Holding the floor
We have recently written about the potential turning point for Value versus Growth which occurred in mid-November.
To recap, we identified a sharp spike in the volatility of the Value / Growth ratio as resembling a similar event in the year 2000, which at that time marked the start of a long period of Value out-performance.
What do we need for the turning point thesis to hold? ... more